Hansoh Pharmaceutical Group Company Limited (3KY.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 09:15AM CET
| Previous Close | 1.6400 |
| Open | 1.6400 |
| Bid | 1.6600 x N/A |
| Ask | 1.7700 x N/A |
| Day's Range | 1.6400 - 1.6400 |
| 52 Week Range | 1.1100 - 2.1600 |
| Volume | |
| Avg. Volume | 329 |
| Market Cap | 10.649B |
| Beta (5Y Monthly) | 0.54 |
| PE Ratio (TTM) | 27.33 |
| EPS (TTM) | 0.0600 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.01 (0.88%) |
| Ex-Dividend Date | Sept 15, 2023 |
| 1y Target Est | N/A |
GlobeNewswireSCYNEXIS and Hansoh Pharma Announce NMPA Acceptance of the New Drug Application for Ibrexafungerp in China
JERSEY CITY, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that China’s National Medical Products Administration (NMPA) has accepted for review a New Drug Application (NDA) for oral ibrexafungerp tablets for the treatment of adult and post-menarchal pediatric females with vulvovaginal candidiasis (VVC) in the Chinese mainland.
© 2023 Yahoo. All rights reserved.